SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-18-027669
Filing Date
2018-01-31
Accepted
2018-01-31 17:26:55
Documents
7
Group Members
VALLEY ACQUISITION SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-C d525966dsctoc.htm SC TO-C 19717
2 EX-99.1 d525966dex991.htm EX-99.1 86321
3 EX-99.2 d525966dex992.htm EX-99.2 3545
4 EX-99.3 d525966dex993.htm EX-99.3 28469
5 EX-99.4 d525966dex994.htm EX-99.4 798
6 EX-99.5 d525966dex995.htm EX-99.5 784
7 GRAPHIC g533529snap4.jpg GRAPHIC 4951
  Complete submission text file 0001193125-18-027669.txt   148448
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filed by) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3101 WESTERN AVE. SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVE. SUITE 600 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Subject) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-84961 | Film No.: 18563846
SIC: 8731 Services-Commercial Physical & Biological Research